Fiorilli Paul, Partridge Darren, Staniszewska Izabela, Wang Jin Y, Grabacka Maja, So Kelvin, Marcinkiewicz Cezary, Reiss Krzysztof, Khalili Kamel, Croul Sidney E
Department of Neuroscience and Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA.
Lab Invest. 2008 Nov;88(11):1143-56. doi: 10.1038/labinvest.2008.89. Epub 2008 Sep 15.
Medulloblastoma spreads by leptomeningeal dissemination rather than by infiltration that characterizes other CNS tumors, eg, gliomas. This study represents an initial attempt to identify both the molecules that mediate medulloblastoma adhesion to leptomeninges and the pathways that are key to survival and proliferation of tumor following adhesion. As a first step in molecule identification, we produced adhesion of D283 medulloblastoma cells to the extracellular matrix (ECM) of H4 glioma cells in vitro. Within this context, D283 cells preferentially expressed the alpha9 and beta1 integrin subunits; antibody and disintegrin blockade of alpha9 and beta1 binding eliminated the adhesion. The H4 ECM was enriched in tenascin, a binding partner for the alpha9beta1 integrin heterodimer. Purified tenascin-C supported D283 cell adhesion. The adhesion was blocked by antibodies to alpha9 and beta1 integrin. In vivo data were similar; immunohistochemistry of primary human medulloblastomas with leptomeningeal extension demonstrated increased expression of alpha9 and beta1 integrins as well as tenascin at the interface of brain and leptomeningeal tumor. These data suggest that tumor-cell expressions of alpha9 and beta1 integrins in combination with extracellular tenascin are necessary for medulloblastoma adhesion to the leptomeninges. As a first step in the identification of pathways that mediate survival and proliferation of tumor following adhesion, we demonstrated that adhesion to H4 ECM was associated with survival and proliferation of D283 cells as well as activation of the MAPK pathway in a growth factor deficient environment. Antibody blockade of alpha9 and beta1 integrin binding that eliminated adhesion also eliminated the in vitro survival benefit. These data suggest that adhesion of medulloblastoma to the meninges is necessary for the survival and proliferation of these tumor cells at the secondary site.
髓母细胞瘤通过软脑膜播散而非像其他中枢神经系统肿瘤(如胶质瘤)那样通过浸润性生长来扩散。本研究首次尝试确定介导髓母细胞瘤与软脑膜黏附的分子以及黏附后肿瘤存活和增殖的关键途径。作为分子鉴定的第一步,我们在体外使D283髓母细胞瘤细胞与H4胶质瘤细胞的细胞外基质(ECM)发生黏附。在此情况下,D283细胞优先表达α9和β1整合素亚基;针对α9和β1结合的抗体及解整合素阻断消除了黏附。H4细胞外基质富含腱生蛋白,它是α9β1整合素异二聚体的结合伴侣。纯化的腱生蛋白-C支持D283细胞黏附。该黏附被α9和β1整合素抗体阻断。体内数据类似;对有软脑膜播散的原发性人类髓母细胞瘤进行免疫组织化学分析显示,在脑与软脑膜肿瘤交界处,α9和β1整合素以及腱生蛋白的表达增加。这些数据表明,α9和β1整合素的肿瘤细胞表达与细胞外腱生蛋白相结合对于髓母细胞瘤与软脑膜的黏附是必需的。作为鉴定黏附后介导肿瘤存活和增殖途径的第一步,我们证明在生长因子缺乏的环境中,与H4细胞外基质的黏附与D283细胞的存活、增殖以及MAPK途径的激活相关。消除黏附的α9和β1整合素结合抗体阻断也消除了体外存活益处。这些数据表明,髓母细胞瘤与脑膜的黏附对于这些肿瘤细胞在继发部位的存活和增殖是必需的。